Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor?
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to
While enrolling subjects is arguably the most crucial aspect of clinical research operations, this cannot be done without activating a
In this episode, Jake Meyer and Candi Barlow review results from Advarra’s recent survey and discuss study activation success strategies for sites.
Clinical trial activation involves a host of tasks, from institutional review board (IRB) tasks and consent form development to
Breaking down barriers to participation in clinical research has long been a challenge, affecting every aspect of the industry. As
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
Study activation is a necessary part of a clinical trial but can be rather difficult to coordinate efficiently. There is
Effective coverage analysis is crucial for billing compliance, helping sites avoid financial penalties and protect their study’s integrity.
In a recent webinar, Advarra experts Constance Cullity and Michele Russell-Einhorn presented FDA Inspections of Clinical Investigators: Understanding the Process
A key element to successful study startup is identifying efficiencies to help meet critical milestones. Engaging with research compliance experts
Budget negotiations reveal hidden costs and extended timelines, underscoring the importance of efficient processes for clinical trial success.
MCA timelines impact trial activation efficiency, with staffing shortages a key barrier. Many sites find sponsors receptive to covering MCA-related costs.